Literature DB >> 11033982

Leptin plasma concentrations are dependent on body fat distribution in obese patients.

A Minocci1, G Savia, R Lucantoni, M E Berselli, M Tagliaferri, G Calò, M L Petroni, C de Medici, G C Viberti, A Liuzzi.   

Abstract

AIM: To evaluate whether fat distribution plays a role in determining serum leptin concentrations. PATIENTS AND METHODS: One-hundred and forty-seven obese patients, 77 males and 70 females, aged 45.1 +/- 13.2 y (mean +/- s.d.; range 21-73 y), with body mass index (BMI) ranging from 30 to 55 kg/m2 (mean 42.3 +/- 5.9). Ultrasound assessment of the thickness of subcutaneous and preperitoneal fat was carried out and calculation of their ratio as abdominal fat index (AFI), waist-hip ratio (WHR), body composition by bioelectrical impedance to evaluate the percentage of fat mass (FM%) and total amount of fat (FMKg) were also determined. Plasma leptin was measured by radio immuno assay (RIA).
RESULTS: In the whole group of patients, serum leptin concentrations were 37.2 +/- 18.4 ng/ml (range 6-101.3 ng/ml); in spite of BMI values not being significantly different, women had leptin values significantly higher (47.4 +/- 17.4 ng/ml) (P < 0.01) than males (28.1 +/- 15.1 ng/ml), also after correction for fat mass. The mean thickness of abdominal subcutaneous fat was 33.7 +/- 12.9 mm and it was significantly (P < 0.001) higher in female (40.9 +/- 10.6 mm) than in male (27.1 +/- 11.2 mm) patients; preperitoneal thickness was 22.9 +/- 7.1 mm, with significantly (P < 0.05) higher values in males (24.2 +/- 6.8 mm) than in females (21.7 +/- 7.3 mm). Accordingly, AFI (in all patients 0.84 +/- 0.6) was significantly higher in males (1.09 +/- 0.6) than in females (0.56 +/- 0.2). In the overall population, leptin concentrations were directly and significantly related to subcutaneous but not preperitoneal fat; they showed a strong inverse relationship with AFI and WHR. When the results were evaluated dividing the patients according to gender, subcutaneous fat thickness showed a stronger association with leptin levels in males than in females, whereas no association was found with preperitoneal fat thickness. Leptin and AFI values were significantly related only in men. WHR values were not correlated with leptin concentrations in either sex. When fat mass was added to the model, subcutaneous fat thickness, AFI and WHR remained independently associated with leptin concentrations. Age and diabetes did not influence these measures.
CONCLUSIONS: Fat distribution contributes to the variability in serum leptin in obese patients. In particular, subcutaneous abdominal fat is a determinant of leptin concentration, also independently of the amount of fat mass, whereas the contribution of preperitoneal visceral fat is not significant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033982     DOI: 10.1038/sj.ijo.0801385

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  36 in total

Review 1.  Metabolic impact of body fat distribution.

Authors:  C Gasteyger; A Tremblay
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

2.  Effects of a 3-week integrated body weight reduction program on leptin levels and body composition in severe obese subjects.

Authors:  A Sartorio; F Agosti; M Resnik; C L Lafortuna
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

3.  Noninvasive evaluation of abdominal fat and liver changes following progressive weight loss in severely obese patients treated with laparoscopic gastric bypass.

Authors:  Federica Del Genio; Gianmattia Del Genio; Ilario De Sio; Maurizio Marra; Lucia Alfonsi; Carmine Finelli; Franco Contaldo; Fabrizio Pasanisi
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

4.  Ultrasonographic visceral fat thickness in the first trimester can predict metabolic syndrome and gestational diabetes mellitus.

Authors:  Esra Bahar Gur; Ozlem Ince; Guluzar Arzu Turan; Muammer Karadeniz; Sumeyra Tatar; Esin Celik; Murat Yalcin; Serkan Guclu
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

5.  Metabolic characterization of overweight and obese adults.

Authors:  Katie R Hirsch; Abbie E Smith-Ryan; Malia N M Blue; Meredith G Mock; Eric T Trexler; Kristin S Ondrak
Journal:  Phys Sportsmed       Date:  2016-11       Impact factor: 2.241

6.  Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

Authors:  E Pardina; M D López-Tejero; R Llamas; R Catalán; R Galard; H Allende; V Vargas; A Lecube; J M Fort; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

Review 7.  Leptin as a Mediator of Obesity-Induced Hypertension.

Authors:  Balyssa B Bell; Kamal Rahmouni
Journal:  Curr Obes Rep       Date:  2016-12

8.  Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: a dose-response study.

Authors:  P Putignano; A Brunani; A Dubini; M Bertolini; R Pasquali; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

9.  Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study.

Authors:  Poghni A Peri-Okonny; Colby Ayers; Naim Maalouf; Sandeep R Das; James A de Lemos; Jarett D Berry; Aslan T Turer; Ian J Neeland; Philipp E Scherer; Wanpen Vongpatanasin
Journal:  Diabetes Metab Res Rev       Date:  2016-08-18       Impact factor: 4.876

10.  Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction.

Authors:  Nergis Ekmen; Aysen Helvaci; Meral Gunaldi; Hadi Sasani; Sembol Turkmen Yildirmak
Journal:  Indian Heart J       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.